A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine
Clinical trial NCT03282227 · COMPLETED
Trial details
- NCT number
- NCT03282227
- Sponsor
- Zosano Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2019-05-17
- Enrollment
- 342
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.